News About: Pharm. Industry
Choongwae jointly to develope cancer therapy with bio company.
Choongwae announced on May 7 about their strategic alliance with Goodcell Life, a subsidiary of Goodgene for a joint development of cellular therapy for cancers by use of natural killer (NK) cells.
According to th...
Diovan soon to be top anti-hypertension drug in Korea.
Novartis Korea established their sales promotional plan for Diovan, an anti-hypertension drug, at the top rank next year.
Novartis Korea said on May 4 that in competition with Cozaar and Aprovel in the ARB anti-hyp...
Drug wholesalers at crossroads
Domestic drug wholesalers, which have played a pivotal role in developing Korean logistic system, are now at a turning point themselves, facing increasing calls for their own changes
The Ministry of Health and Wel...
Shinpoong, MMV launch Phase III clinical trials for anti-malaria drug
Shinpoong Pharm and the Medicines for Malaria Venture (MMV) are conducting the Phase III clinical trials for PYRAMAX, pyronaridine-artesunate, a new artemisinin-based combination treatment (ACT) for malaria.
The st...
Leading pharmaceutical firms' quarterly sales improve
Korea's major drug makers reported two-digit growth in its sales on average during the first three months of this year, citing improved business performance.
Experts attributed better business performance of ...
SERI to predict BT as nation's driving engine after a decade.
"Bio industry is the most viable and only area for Korea to do with good competitiveness" said Dr. Chung Koo-jyun, director of Samsung Economic Research Institute (SERI).
Dr. Chung said in the 3rd Pharma Forum of S...
46 drug makers to build cleaner pharmaceutical distribution channel
46 member companies of the Korea Pharmaceutical Manufacturers Association (KPMA) will adopt a fair trade compliance program at Marriot Hotel on May 9 to ensure their corporate reform in a rapidly changing atmosphere.
...
Pay attention to drug companies whose large shares owned by foreigner.
Rank
Company
Share rate
1
Samil
56.7
2
Handok
53.4
3
Boryung
33.9
4
Hanmi
32.8
5
Il Dong
28.0
6
Yuhan
23.1
7
Hyundai
18.4
...
Korea should depend on biopharmaceuticals
Domestic drug makers should focus on research and development of new biodrugs to survive in an era of the Korea-U.S. FTA via closer collaboration among related circles to innovate internal structures, said Chung Koo-h...
SK Chemical to be splitted from SK Groups.
The SK group transformation into SK Holdings, a stock holding company system put 7 SK subsidiaries such as SK Telecom and SK energy chemical put under the umbrella of SK Holdings Inc but other 7 affiliates including S...
